It should be noted that CZ017 had a different tumor subtype (ERlow+, PR-, and HER2-) from the other 5 patients (cf.Fig. S1H) and had undergone neoadjuvant therapy prior to surgery, while CZ022’s tumor had a significant fraction of fatty tissues. Here, ERBB2 is linked to neoplasm.